Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Bortezomib Consolidation after Nonmyeloablative Allogeneic Transplant Is Safe and Leads to a High Incidence of Immunophenotypic Complete Response in High-Risk or Young Myeloma Patients

Richard LeBlanc, MDFRCPC, Imran Ahmad, MD M.Sc., Rafik Terra, PhD, Séverine Landais, PhD, Michael Sebag, MD PhD, Emilie Lemieux-Blanchard, MD, Nadia M. Bambace, MD, Léa Bernard, MD, Sandra Cohen, MD, Jean-Sébastien Delisle, MD PhD, Thomas Kiss, MD, Silvy Lachance, MDFRCPC, Denis-Claude Roy, MD, Guy Sauvageau, MD PhD, Jean Roy, MD

Blood (2017) 130 (Supplement 1): 4556.

https://doi.org/10.1182/blood.V130.Suppl_1.4556.4556

Published: 2017

Journal Articles

Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients

Richard LeBlanc, MD, Imran Ahmad, MD, Rafik Terra, PhD, Séverine Landais, PhD, Michael Sebag, MD PhD, Emilie Lemieux-Blanchard, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Sandra Cohen, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Silvy Lachance, MD, Denis-Claude Roy, MD, Guy Sauvageau, MD PhD, Jean Roy, MD

Blood (2016) 128 (22): 2306.

https://doi.org/10.1182/blood.V128.22.2306.2306

Published: 2016

Journal Articles

Evaluation of the Impact of Hematopoietic Stem Cell Transplant on the Quality of Life of Elderly Patients Treated for Lymphoma

Christopher Lemieux, MD, Nadia M. Bambace, MD, Jean Roy, MD, Sandra Cohen, MD, Imran Ahmad, MD, Lea Bernard, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Silvy Lachance, MD

Blood (2016) 128 (22): 4788.

https://doi.org/10.1182/blood.V128.22.4788.4788

Published: 2016

Journal Articles

Tandem Autologous Followed By Nonmyeloablative Allogeneic Transplantation in Relapsed High Risk Follicular Lymphoma Leads to Excellent Long Term Progression-Free Survival after 8 Years of Follow-up

Magalie Tardif, MSc, MD Student, Imran Ahmad, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Lambert Busque, MD PhD FRCPC, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Isabelle Fleury, MD, Silvy Lachance, MD, Luigina Mollica, MD PhD, Céline Nkoué, MD, Denis-Claude Roy, MD, Jean Roy, MD, Sandra Cohen, MD

Blood (2016) 128 (22): 4677.

https://doi.org/10.1182/blood.V128.22.4677.4677

Published: 2016

Journal Articles

Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome

Christopher Lemieux, MD, Imran Ahmad, MD, Nadia M. Bambace, MD, Lea Bernard, MD, Sandra Cohen, MD, Jean-Sebastien Delisle, MD PhD, Thomas Kiss, MD, Jean Roy, MD PhD, Silvy Lachance, MD

Blood (2015) 126 (23): 3171.

https://doi.org/10.1182/blood.V126.23.3171.3171

Published: 2015

Journal Articles

High Progression-Free Survival At 10 Years After Tandem Autologous/Nonmyeloablative Allogeneic Transplants For Multiple Myeloma In a Cohort Of 93 Patients: Impact Of Disease Remission Status At Transplant and Chronic Graft-Versus-Host Disease

Imran Ahmad, MD, MSc, Sandra Cohen, MD, Silvy Lachance, MD, Guy Sauvageau, MD, PhD, Thomas Kiss, MD, Lambert Busque, MD, Denis-Claude Roy, MD, Jean-Sebastien Delisle, MD, PhD, Lea Bernard, MD, Richard LeBlanc, MD, Jean Roy, MD

Blood (2013) 122 (21): 3353.

https://doi.org/10.1182/blood.V122.21.3353.3353

Published: 2013

Journal Articles

Pre-Transplant Remission Status and Peripheral Blood Stem Cell Graft Contribute To Long-Term Outcome After Myeloablative Sibling-Donor Allogeneic Transplant For Multiple Myeloma

Imran Ahmad, MD, MSc, Sandra Cohen, MD, Silvy Lachance, MD, Guy Sauvageau, MD, PhD, Denis-Claude Roy, MD, Lambert Busque, MD, Thomas Kiss, MD, Jean-Sebastien Delisle, MD, PhD, Lea Bernard, MD, Richard LeBlanc, MD, Jean Roy, MD

Blood (2013) 122 (21): 5541.

https://doi.org/10.1182/blood.V122.21.5541.5541

Published: 2013

Journal Articles

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

Denis-Claude Roy, MD, Mireille Guerin, MSc, Radia Sidi Boumedine, MSc, Silvy Lachance, MD, Sandra Cohen, MD, Guy Sauvageau, MD, PhD, Thomas Kiss, MD, Lambert Busque, MD, Jean Morin, Marie-Claude Guertin, PhD, Andrea Velardi, MD, PhD, Katayoun Rezvani, MD, PhD, Stephan Mielke, MD, R. Maarten Egeler, MD, PhD, A. John Barrett, MD, Claude Perreault, MD, Jean Roy, MD

Blood (2011) 118 (21): 3020.

https://doi.org/10.1182/blood.V118.21.3020.3020

Published: 2011

Journal Articles

High Dose Valacyclovir Is Highly Effective to Prevent Cytomegalovirus and Other Herpes Viruses Viremia After Allogeneic Stem Cell Transplantation.

Marie Detrait, Guy Boivin, Robert Delage, Claire Béliveau, Annie-Claude Labbé, Sandra Cohen, Thomas Kiss, Lambert Busque, Denis-Claude Roy, Guy Sauvageau, Jean Roy

Blood (2009) 114 (22): 1140.

https://doi.org/10.1182/blood.V114.22.1140.1140

Published: 2009

Journal Articles

Collagen and Elastin Degradation Products as Potential Biomarkers for Chronic Graft-Versus-Host Disease (cGVHD).

Imran Ahmad, MD, Michel Boutin, PhD, Pierre Thibault, PhD, Lambert Busque, MD, Sandra Cohen, MD, Thomas Kiss, MD, Silvy Lachance, MD, Denis-Claude Roy, MD, Guy Sauvageau, MD, PhD, Jean Roy, MD

Blood (2009) 114 (22): 1156.

https://doi.org/10.1182/blood.V114.22.1156.1156

Published: 2009

Journal Articles

Tandem Autologous-Allogeneic Nonmyeloablative Sibling Transplant in Relapsed Follicular Lymphoma Leads to Impressive Progression Free Survival with Minimal Toxicity.

Sandra Cohen, MD, Lambert Busque, MD, Thomas Kiss, MD, Silvy Lachance, MD, Denis-Claude Roy, MD, Guy Sauvageau, MD, PhD, Jean Roy, MD

Blood (2009) 114 (22): 50.

https://doi.org/10.1182/blood.V114.22.50.50

Published: 2009

Journal Articles

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

Denis-Claude Roy, MD, Silvy Lachance, MD, Thomas Kiss, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Guy Sauvageau, MD, PhD, Maarten Egeler, MD, Jean Roy, MD

Blood (2009) 114 (22): 512.

https://doi.org/10.1182/blood.V114.22.512.512

Published: 2009

Journal Articles

First Line Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma (MCL).

Silvy Lachance, MD, Cecile Molucon-Chabrot, Lambert Busque, Thomas Kiss, MD, Sandra Cohen, Denis-Claude Roy, MD, Jean Roy, MD, Guy Sauvageau, MD, PhD

Blood (2009) 114 (22): 3366.

https://doi.org/10.1182/blood.V114.22.3366.3366

Published: 2009

Journal Articles

Tandem Autologous-Nonmyeloablative (NMA) Allogeneic(Allo) Transplant (Tx) in Newly Diagnosed Multiple Myeloma (MM) Leads to Improved Survival When Compared to Conventional Allogeneic Transplant

Waleed Sabry, Amelie Fontaine, MD, Richard Le Blanc, MD, PhD, Guy Sauvageau, Denis-Claude Roy, Lambert Busque, Sandra Cohen, Thomas Kiss, Silvy Lachance, Jean Roy

Blood (2008) 112 (11): 3299.

https://doi.org/10.1182/blood.V112.11.3299.3299

Published: 2008

Journal Articles

Graft-Versus-Host Disease (Gvhd) Prophylaxis with Tacrolimus and Mycophenolate Mofetil (MMF) in 131 Matched Sibling Nonmyeloablative (NMA) Transplant Recipients: Long-Term Follow-up Confirms Extremely Low Incidence of Acute (a) Gvhd, High Incidence of Extensive Chronic (c) Gvhd and Favorable Disease Outcome.

Waleed Sabry, Annie-Claude Labbé, Richard Le Blanc, MD, PhD, Guy Sauvageau, Denis-Claude Roy, Lambert Busque, Sandra Cohen, Thomas Kiss, Silvy Lachance, Jean Roy, MD

Blood (2008) 112 (11): 1176.

https://doi.org/10.1182/blood.V112.11.1176.1176

Published: 2008

Journal Articles

Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.

Denis-Claude Roy, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Thomas Kiss, MD, Silvy Lachance, MD, Guy Sauvageau, MD, Pierre Caudrelier, MD, Jean Roy, MD

Blood (2007) 110 (11): 2976.

https://doi.org/10.1182/blood.V110.11.2976.2976

Published: 2007

Journal Articles

Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.

Denis-Claude Roy, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Thomas Kiss, MD, Silvy Lachance, MD, Guy Sauvageau, MD, Pierre Caudrelier, MD, Jean Roy, MD

Blood (2006) 108 (11): 309.

https://doi.org/10.1182/blood.V108.11.309.309

Published: 2006

Journal Articles

Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss

Ian Thornley, Robert Sutherland, Robert Wynn, Rakash Nayar, Lillian Sung, George Corpus, Thomas Kiss, Jeff Lipton, John Doyle, Fred Saunders, Suzanne Kamel-Reid, Melvin Freedman, Hans Messner

Blood (2002) 99 (7): 2387–2396.

https://doi.org/10.1182/blood.V99.7.2387

Published: 2002

NARROW

Bortezomib Consolidation after Nonmyeloablative Allogeneic Transplant Is Safe and Leads to a High Incidence of Immunophenotypic Complete Response in High-Risk or Young Myeloma Patients

Bortezomib Consolidation after Nonmyeloablative Allogeneic Stem Cell Transplantation Leads to a High Incidence of Immunophenotypic Complete Response in Young and/or High-Risk Multiple Myeloma Patients

Evaluation of the Impact of Hematopoietic Stem Cell Transplant on the Quality of Life of Elderly Patients Treated for Lymphoma

Tandem Autologous Followed By Nonmyeloablative Allogeneic Transplantation in Relapsed High Risk Follicular Lymphoma Leads to Excellent Long Term Progression-Free Survival after 8 Years of Follow-up

Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Elderly Patients with Lymphoma: Chemosensitive Disease Rather Than Age or Co-Morbidity Index Predicts Outcome

High Progression-Free Survival At 10 Years After Tandem Autologous/Nonmyeloablative Allogeneic Transplants For Multiple Myeloma In a Cohort Of 93 Patients: Impact Of Disease Remission Status At Transplant and Chronic Graft-Versus-Host Disease

Pre-Transplant Remission Status and Peripheral Blood Stem Cell Graft Contribute To Long-Term Outcome After Myeloablative Sibling-Donor Allogeneic Transplant For Multiple Myeloma

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

High Dose Valacyclovir Is Highly Effective to Prevent Cytomegalovirus and Other Herpes Viruses Viremia After Allogeneic Stem Cell Transplantation.

Collagen and Elastin Degradation Products as Potential Biomarkers for Chronic Graft-Versus-Host Disease (cGVHD).

Tandem Autologous-Allogeneic Nonmyeloablative Sibling Transplant in Relapsed Follicular Lymphoma Leads to Impressive Progression Free Survival with Minimal Toxicity.

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

First Line Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma (MCL).

Tandem Autologous-Nonmyeloablative (NMA) Allogeneic(Allo) Transplant (Tx) in Newly Diagnosed Multiple Myeloma (MM) Leads to Improved Survival When Compared to Conventional Allogeneic Transplant

Phase I Clinical Trial of Haplotype Mismatched Myeloablative Stem Cell Transplantation: Higher Doses of Donor Lymphocyte Infusions Depleted of Alloreactive Cells Using ATIR May Improve Outcome without Causing GVHD.

Phase I Clinical Study of Donor Lymphocyte Infusion Depleted of Alloreactive T Cells after Haplotype Mismatched Myeloablative Stem Cell Transplantation To Limit Infections and Malignant Relapse without Causing GVHD.

Early hematopoietic reconstitution after clinical stem cell transplantation: evidence for stochastic stem cell behavior and limited acceleration in telomere loss

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only